Tr Kanaga Sabapathy

Title: Tr Kanaga Sabapathy: Innovator in Antibody Development

Introduction

Tr Kanaga Sabapathy is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting mutant p53 polypeptides. With a total of 2 patents, his work has implications for cancer diagnosis and treatment.

Latest Patents

His latest patents focus on the production of anti-p53 antibodies. The first patent describes methods for creating an antibody that is specific for a mutant p53 polypeptide over the wildtype variant. This involves using an immunogen that includes an antigen sequence from the mutant p53 polypeptide, along with a scaffold sequence to ensure the antigen is presented in a solvent-accessible configuration. The second patent similarly outlines methods for producing antibodies against mutant p53, specifically targeting mutations such as R175H, R248Q, or R273H. These antibodies have potential uses in diagnosing, prognosing, and stratifying patient groups, as well as in imaging and treating cancer.

Career Highlights

Tr Kanaga Sabapathy has worked with prominent organizations such as the Agency for Science, Technology and Research and Singapore Health Services Pte Ltd. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in the field.

Collaborations

He has collaborated with notable colleagues, including Liew Oi Wah and Xin Yu Koh, which has further enriched his research endeavors.

Conclusion

Tr Kanaga Sabapathy's work in developing specific antibodies for mutant p53 polypeptides showcases his innovative spirit and dedication to advancing cancer research. His contributions are vital for improving diagnostic and therapeutic strategies in oncology.